| Indolent T-Cell Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived41 of 41show fewer |
|---|
| → investigated in trials for | Brentuximab Vedotinadc 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aminolevulinic Acidsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlormethinesmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Interferon Alfa-2bother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Indolent T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |